Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Phase II Study of the Combination of AZD6244 Hydrogen Sulfate and MK-2206 in Patients With Refractory Advanced Biliary Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01859182
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:37.891614+00:00
Published At
2014-09-09T00:00:00+00:00
Record Updated At
2014-09-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adenocarcinoma of the Gallbladder", "Adenocarcinoma With Squamous Metaplasia of the Gallbladder", "Adult Primary Cholangiocellular Carcinoma", "Advanced Adult Primary Liver Cancer", "Cholangiocarcinoma of the Extrahepatic Bile Duct", "Localized Unresectable Adult Primary Liver Cancer", "Metastatic Extrahepatic Bile Duct Cancer", "Recurrent Adult Primary Liver Cancer", "Recurrent Extrahepatic Bile Duct Cancer", "Stage II Gallbladder Cancer", "Stage IIIA Gallbladder Cancer", "Stage IIIB Gallbladder Cancer", "Stage IVA Gallbladder Cancer", "Stage IVB Gallbladder Cancer", "Unresectable Extrahepatic Bile Duct Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-09-09"
protocolSection.identificationModule.nctId
"NCT01859182"
protocolSection.identificationModule.officialTitle
"A Multicenter Phase II Study of the Combination of AZD6244 Hydrogen Sulfate and MK-2206 in Patients With Refractory Advanced Biliary Cancers"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Adenocarcinoma of the Gallbladder (protocolSection.conditionsModule.conditions)
  • Adenocarcinoma With Squamous Metaplasia of the Gallbladder (protocolSection.conditionsModule.conditions)
  • Adult Primary Cholangiocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Adult Primary Liver Cancer (protocolSection.conditionsModule.conditions)
  • Cholangiocarcinoma of the Extrahepatic Bile Duct (protocolSection.conditionsModule.conditions)
  • Localized Unresectable Adult Primary Liver Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Extrahepatic Bile Duct Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Primary Liver Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Extrahepatic Bile Duct Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Unresectable Extrahepatic Bile Duct Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.